Background: Endosonographic features of c-kit-positive gastrointestinal stromal tumors (GISTs) were compared with those of leiomyomas and schwannomas. Methods: Twenty-four patients with gastric mesenchymal tumors who underwent endoscopic ultrasonography (EUS) and surgical treatment were enrolled. GISTs were defined as c-kit (CD117)-positive tumors, leiomyomas as desmin-positive and c-kit-negative tumors, and schwannomas as S-100 -positive and c-kit-negative tumors. Invasion to adjacent organs or more than 20 mitotic counts per 50 high power fields indicated malignancy. Results: There were 19 GISTs, three leiomyomas, and two schwannomas. All five malignant tumors were GISTs. A marginal halo was found in 12 of 19 GISTs and in both of the schwannomas, but not in any of the three leiomyomas. The echogenicities of GISTs were low but higher than that of the normal proper muscle layer, whereas those of leiomyomas and schwannomas were usually low. Lobulation of the tumor surface was documented only in GISTs, particularly in malignant ones. The tumor doubling time of a malignant GIST was 9.3 months, and that of six benign GISTs was 18.7 months (range ϭ 10.7-28.0 months). Conclusion: Marginal halo and relatively higher echogenicity on EUS might suggest GIST. Marginal lobulation and a short doubling time may be signs of a malignant GIST.
Mesenchymal tumors of the gastrointestinal tract are usually discovered incidentally during upper gastrointestinal examinations for unrelated conditions, although occasionally larger tumors may cause bleeding [1] . Pathologically, most of these tumors are completely or partly composed of spindle cells and have a light-microscopic appearance suggestive of smooth muscle or nerve sheath differentiation. These tumors therefore have been presumed to be of smooth muscle origin and often labeled as leiomyomatous or Schwann cell tumors [1, 2] . In recent years, with the advance of immunohistochemical [3, 4] and ultrastructural [5] studies, it has been clarified that most gastric and small intestinal mesenchymal tumors are neither leiomyomas nor schwannomas but gastrointestinal stromal tumors (GISTs) derived from the interstitial cells of Cajal [1] [2] [3] [4] [5] .
The c-kit proto-oncogene, which encodes a growth factor receptor with tyrosine kinase activity, has been postulated to play an important role in tumorgenesis because increased function mutations in this gene, localized to chromosome 4q11-21, are being increasingly identified in hereditary and sporadic cases [6, 7] .
It has been reported that most gastrointestinal mesenchymal tumors are benign, but 10 -30% are malignant [1, 2] . Thus, the differentiation of malignant from benign gastric mesenchymal tumors is essential to clinical management. Endoscopic ultrasonography (EUS) is a valuable imaging tool of this neoplasm because it allows the demonstration of a hypoechoic mass that is contiguous with the fourth hypoechoic layer of the normal gut wall [8 -10] . However, the studies are still few, and the ability of EUS to distinguish between benign and malignant mesenchymal tumors remains to be confirmed. Further, little is known about the differentiation by EUS of GISTs, leiomyomas, and schwannomas. In the present study, we evaluated the EUS features of c-kit-positive GISTs in comparison with those of leiomyomas and schwannomas. We then tried to differentiate malignant from benign c-kit-positive GISTs.
Materials and methods
From August 1991 to April 2001, 58 patients with gastric submucosal tumor visited the outpatient clinic of the Cancer Research Institute Hospital of Kanazawa University to undergo EUS examination. All underwent at least one EUS examination. Twenty-four underwent surgical therapy after providing written informed consent because they showed some malignant features or increase in size. There were 14 men and 10 women, with a mean age of 55.4 years (range ϭ 28 -74 years). The tumors were proved to be gastric mesenchymal tumors histopathologically and were classified immunohistochemically as GISTs, leiomyomas, and schwannomas according to the definition by Miettinen et al. [4] . Specifically, GISTs were defined as c-kit (CD117)-positive tumors (Fig.  1A,B) , leiomyomas as desmin-positive and c-kit-negative tumors; and schwannomas as S-100 -positive and c-kitnegative tumors. The presence of peritoneal metastasis and invasion to adjacent organs at surgery were the most reliable signs of malignancy. More than 20 mitotic activities in each of 50 high power fields (HPF) on hematoxylin and eosin staining also indicated malignancy (Fig. 1C) [11] . Tumors with a mitotic frequency of fewer than five per 50 HPF were classified as benign, and tumors larger than 5 cm or with mitotic rates between five and 20 per 50 HPF were classified as borderline.
EUS was performed with conventional ultrasound endoscopes such as the Olympus GF-UM20, 200, or Q240 (7.5 and 12 MHz; Olympus Optical Co., Ltd., Tokyo, Japan) except for two small lesions examined by a miniature probe such as the Olympus UM-2R and 3R. Scanning of the tumor was performed after filling the stomach with 400 -600 mL of deaereated water. About 30 -40 endosonograms were recorded for each patient, and images were recorded on videotapes or magnetooptical disks. On EUS the size of the tumor in two diameters, direction of tumor growth, features of the tumor surface, particularly of the extralumenal surface, and the level and character of internal echo were evaluated and recorded at each examination. Tumor doubling time was determined in cases in which EUS was performed twice or more during a follow-up period of more than 10 months. 
GIST, gastrointestinal stromal tumor; NSE, neuron-specific enolase; S-100, S-100 protein; SMA, smooth muscle actin 
A, the lower portion; C, the upper portion; DT, doubling time (months); GIST, gastrointestinal stromal tumor; M, the middle portion; ND, not determined
Results
As shown in Table 1 and Figure 1 , immunohistochemical analyses demonstrated 19 cases as GISTs, three as leiomyomas, and two as schwannomas. Five malignant tumors were diagnosed as GISTs. Table 2 shows the distribution of tumor size of all mesenchymal tumors according to malignancy. The maximum diameter of the malignant GISTs ranged from 22 to 82 mm (mean ϭ 56.2 mm), and that of the benign and borderline GISTs ranged from 19 to 62 mm (mean ϭ 36.9 mm). The maximum diameters of the three leiomyomas were 19, 30, and 46 mm and those of the two schwannomas were 23 and 32 mm. Endosonographically, the echogenicities of GISTs were usually low but slightly higher than that of the surrounding normal proper muscle layer. Twelve of 19 GISTs had a marginal halo in some form and showed the bull's eye sign ( Table 2 , Fig. 2A ). In contrast, three leiomyomas had no distinct marginal halo (Table 2) . They had high echo lines or networks particularly at the periphery of the tumor, and their echogenicities were nearly equal to that of the normal surrounding proper muscle layer (Fig. 2B) . Two schwannomas had marginal halo and homogeneous internal echo (Table 2) . Their echogenicities were extremely low (Fig. 2C) . Histopathologic examination showed that marginal halos on EUS observed in GISTs and schwannomas corresponded to the oppressed muscle layer and lymphoid cuff, respectively (Fig. 2D,F) . As shown in Table 2 and Figures 3 and 4 , lobulation of the tumor surface, particularly of the extralumenal surface, was found in all the malignant GISTs, whereas only three of 14 benign and borderline GISTs and one of three leiomyomas had this feature. The incidence of lobulation in the malignant GISTs was significantly higher than that in benign and borderline GISTs (Fig. 5) . Cystic changes, echogenic foci (high spots), and calcifications within the tumor were observed only in GISTs irrespective of the malignant nature, whereas exogastric growth was commonly seen in the three mesenchymal tumors (Table 2 , Fig. 4 ). Tumor doubling time was determined in seven patients; i.e., one malignant GIST and six benign GISTs. Tumor doubling time of the patient with malignant GIST was 9.3 months, and that of the six patients with benign GISTs was 10.7-28.0 (mean ϭ 18.7) months (Table 2) .
Discussion
GISTs are usually positive for c-kit, often positive for CD34, and sometimes positive for smooth muscle actin [2] [3] [4] . Clinical application of these antibodies has al- lowed for the differentiation of gastrointestinal mesenchymal tumors according to histogenesis [1] [2] [3] [4] . In the present study, we realized that most gastric mesenchymal tumors are neither leiomyomas nor schwannomas but rather GISTs derived from the interstitial cells of Cajal, as shown in the literature [1] [2] [3] [4] [5] . We also found that the malignant mesenchymal tumors are usually seen in groups of GISTs, despite the limited number of cases observed here.
In clinical practice, preoperative differentiation between these gastrointestinal mesenchymal tumors according to histogenesis is usually difficult, even if EUSguided fine-needle aspiration is indicated [12] [13] [14] . In the present study, we tried to differentiate between these gastric mesenchymal tumors by the imaging method of EUS. Complete or incomplete marginal hypoechoic halo was found in more than half of the patients with GISTs and schwannomas, whereas a distinct marginal halo was not seen in leiomyomas. It is well known that a hypoechoic halo is a characteristic ultrasonographic sign of malignant liver tumors such as hepatocellular carcinoma or metastatic liver cancer [15] . A pseudocapsule of the collapsed surrounding tissues owing to an expansively growing tumor is thought to be the cause of the halo in malignant liver tumors [15] . In GISTs and schwannomas, pathologic examination disclosed that tumor cells were partly or completely circumscribed by the residual muscle tissues of the surrounding muscularis propria, which formed a capsulelike structure, the same as in a previous pathologic study [11] . Therefore, it is presumed that the halo in GISTs and schwannomas might be formed as the tumors increased in size in the same manner as malignant liver tumors. In this study, it was also demonstrated that the echogenicities of GISTs were generally low but slightly higher than that of the normal surrounding proper muscle layer, whereas the level of leiomyomas was nearly equal to that of the surrounding normal proper muscle layer and that of schwannoma was extremely low. Pathologically, it is well known that the cellularity of leiomyomas are nominal to moderate with eosinophilic cytoplasm, whereas GISTs show a higher overall cellularity, creating a basophilic appearance on a slide stained with hematoxylin and eosin [1] [2] [3] [4] [5] . It also has been documented that schwannomas often have scattered lymphocytes showing a lymphoid cuff with spindle cells in a fibrous band [16] . Accordingly, the difference in echogenicities among the three mesenchymal tumors might reflect these pathologic differences of cellularity and structural components of tumor. However, these results must be confirmed with a much larger number of patients because the number of patients enrolled in the present study was too small to make a comparison.
Malignant mesenchymal tumor of the stomach was called leiomyosarcoma until quite recently [1, 2] . It is usually a large tumor showing strong mitotic activity on pathologic examination. In our series, however, there was no significant difference in tumor size between malignant and benign GISTs. Therefore, tumor size itself is not likely to be a sign of malignancy, if a study enrolls patients are discovered incidentally in an asymptomatic phase by routine endoscopic studies. Appelman and Helwig [11] reported that the most distinctive gross pathologic feature of malignant gastric mesenchymal tumors is lobulation. It is interesting that we could detect this feature by using EUS in all patients with malignant GISTs. They also reported that exogastric growth and cystic cavities often communicating with the ulceration on the lumenal surface are common features seen in gastric sarcomas [11] . In the previous studies on EUS, it also has been pointed out that exogastric growth, cystic changes within the tumor, echogenic foci in the tumor, presence of lymph nodes, and nodularity or irregularity of the tumor favored a diagnosis of malignant gastrointestinal mesenchymal tumor [8 -10] . In the present study, we indeed realized the accuracy of EUS in assessment of these pathologic features. However, exogastric growth, cystic changes, and echogenic foci within the tumor were unrelated to malignancy, whereas lobulation of the tumor surface was significantly often observed in the malignant GISTs. Therefore, we believe that lobulation of the tumor surface might be an essential feature of malignant GISTs and become the most reliable indicator of malignancy.
In the present study, we could determine the tumor doubling time in seven cases, one malignant GIST and six benign GISTs. Several investigators reported that the doubling time of malignant gastric mesenchymal tumors is usually shorter than one year [17] [18] [19] [20] . According to their reports, the mean tumor doubling time of malignant gastric mesenchymal tumors was 9.4 months (3.6 -11.5), 7.7 months (4.2-12.6), and 9.6 months (3.0 -14.9), whereas that of benign tumors was 16.6 months (8.3-24.1), 36.0 months (8.1-95.1), and 51.0 months (21.5-119.1) [17] [18] [19] . Our data are in agreement with those reports. Thus, a short doubling time might be another indicator of malignant GISTs.
In conclusion, EUS is useful to diagnose and manage gastric mesenchymal tumors. A marginal halo and relatively higher echogenicity on EUS suggest GIST. Lobulation of the tumor surface, particularly on the extralumenal side, might be the most reliable sign of malignancy. An endosonographic follow-up in at least 1 year is recommended even if the tumor is small, because malignant GISTs have short tumor doubling times, usually shorter than 1 year. Surgical treatment should be considered if the tumor has a lobulated surface or the tumor doubling time is short. We hope that an immunohistochemical and genetic approach using sufficient biopsied samples with or without EUS guidance will improve the diagnosis of gastrointestinal mesenchymal tumors and their malignancy. 306 T. Okai et al.: EUS of c-kit-positive GIST
